About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
https://www.soho2019.com/
Hodgkin Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Meet The Professor Sessions
Chronic Myeloid Leukemia
Myeloproliferative Neoplasms
Breakfast With The Expert
Independent Satellite Symposium
Plenary Sessions
Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options
Acute Lymphoblastic Leukemia
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Indolent B-cell Lymphoma
Mantle Cell Lymphoma
Aggressive B-cell Lymphoma
T-cell Lymphoma
Cellular Therapy
Next Questions
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
G
Next Questions in Myelodysplastic Syndromes: New Approaches for Anemia, HMAs, Targeting TP53, and Integration of alloSCT
By
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
FEATURING
Guillermo Garcia-Manero
By
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
FEATURING
Guillermo Garcia-Manero
11 views
October 18, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Next Questions
11:45
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Next Questions in ALL: Non-Chemo Regimes, The Use of Bcl2-Bclxl Inhi…
Feat.
H. Kantarjian
10:56
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Next Questions in AML: Incorporation of New Therapies, Which Patient…
Feat.
E. Wang
09:48
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Automated and Decentralized CAR-T Cell Manufacture: Enabling Local M…
Feat.
B. Dropulic
07:40
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
CLL Next Questions: How To Achieve Undetectable MRD & Cure More …
Feat.
W. Wierda
27:31
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Moving Next-Generation TKIs Into Earlier Lines of Therapy - How I Tr…
Feat.
E. Jabbour
07:09
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Next Questions in DLBCL: New Genetic Classification Based Selection …
Feat.
A. Younes
10:49
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Follicular Lymphoma - Next Steps: What is the First-Line Standard in…
Feat.
R. Marcus
10:18
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Next Qs in Peripheral T-Cell Lymphoma: the Advancement of Care, Impa…
Feat.
O. O’Connor
08:13
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Next Questions in Mantle Cell Lymphoma: Do We Need Chemo at All; Is …
Feat.
S. Rule
08:39
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Next Questions in Hodgkin Lymphoma: Brentuximab Vedotin/PD-1+AVD as …
Feat.
S. Ansell
10:18
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Next Questions in Myelodysplastic Syndromes: New Approaches for Anem…
Feat.
G. Garcia-Manero
12:02
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Next Questions in Myeloproliferative Neoplasms: What Antibody Format…
Feat.
S. Verstovsek
